Cargando…

Long-Term Outcomes of Stereotactic Body Radiotherapy (SBRT) for Intraprostatic Relapse after Definitive Radiotherapy for Prostate Cancer: Patterns of Failure and Association between Volume of Irradiation and Late Toxicity

SIMPLE SUMMARY: Despite advancements in prostate cancer treatment, local recurrence remains among the most common patterns of failure. A recent meta-analysis has shown that, in patients initially treated with radiotherapy, salvage re-irradiation seems to be associated with the most favorable toxicit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miszczyk, Marcin, Kraszkiewicz, Małgorzata, Moll, Matthias, Kaminiów, Konrad, Sobel, Szymon, Dolla, Łukasz, Wojcieszek, Piotr, Rajwa, Paweł, Yanagisawa, Takafumi, Nowicka, Zuzanna, Shariat, Shahrokh F., Goldner, Gregor, Miszczyk, Leszek, Majewski, Wojciech
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954604/ https://www.ncbi.nlm.nih.gov/pubmed/36831523 http://dx.doi.org/10.3390/cancers15041180

Ejemplares similares

Ultra-Hypofractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer: Clinical Outcomes, Patterns of Recurrence, Feasibility of Definitive Salvage Treatment, and Competing Oncological Risk
por: Miszczyk, Marcin, et al.
Publicado: (2022)

Stereotactic Ablative Radiotherapy for Prostate Cancer—The Treatment Results of 500 Patients and Analysis of Failures
por: Miszczyk, Leszek, et al.
Publicado: (2019)

Stereotactic linac radiosurgery and hypofractionated stereotactic radiotherapy for pediatric arteriovenous malformations of the brain: experiences of a single institution
por: Blamek, Sławomir, et al.
Publicado: (2012)

Prognostic Factors in Postoperative Radiotherapy for Prostate Cancer – Tertiary Center Experience
por: Miszczyk, Marcin, et al.
Publicado: (2021)

Do We Need Radiotherapy in Grade II Ependymoma?
por: Napieralska, Aleksandra, et al.
Publicado: (2022)

Hematologic Toxicity of Conformal Radiotherapy and Intensity Modulated Radiotherapy in Prostate and Bladder Cancer Patients
por: Miszczyk, Marcin, et al.
Publicado: (2018)

Pre-Treatment Hemoglobin Concentration and Absolute Monocyte Count as Independent Prognostic Factors for Survival in Localized or Locally Advanced Prostate Cancer Patients Undergoing Radiotherapy
por: Magrowski, Łukasz, et al.
Publicado: (2022)

Stereotactic radiotherapy in epithelial ovarian cancer brain metastases patients
por: Celejewska, Agata, et al.
Publicado: (2014)

Evaluation of efficacy and safety of robotic stereotactic body radiosurgery and hypofractionated stereotactic radiotherapy for vertebral metastases
por: Księżniak-Baran, Dorota, et al.
Publicado: (2015)

Hypofractionated stereotactic radiotherapy for large or involving critical organs cerebral arteriovenous malformations
por: Blamek, Sławomir, et al.
Publicado: (2013)

Histopathological Examination of an Explanted Heart in a Long-Term Responder to Cardiac Stereotactic Body Radiotherapy (STereotactic Arrhythmia Radioablation)
por: Miszczyk, Marcin, et al.
Publicado: (2022)

Prostate-specific antigen kinetics and metastasis-free survival in patients treated with external beam radiotherapy combined with high-dose-rate brachytherapy boost and androgen deprivation therapy for localized prostate cancer
por: Miszczyk, Marcin, et al.
Publicado: (2022)

The Intraprostatic Immune Environment after Stereotactic Body Radiotherapy is Dominated by Myeloid Cells
por: Nickols, Nicholas G., et al.
Publicado: (2020)

The Prognostic Value of PI-RADS Score in CyberKnife Ultra-Hypofractionated Radiotherapy for Localized Prostate Cancer
por: Miszczyk, Marcin, et al.
Publicado: (2022)

Stereotactic Body Radiotherapy (SBRT) for Intrahepatic and Hilar Cholangiocarcinoma
por: Mahadevan, Anand, et al.
Publicado: (2015)

Editorial: Novel Applications of Stereotactic Body Radiotherapy (SBRT)
por: Kotecha, Rupesh, et al.
Publicado: (2021)

A comparison of treatment outcome between fiducial-based and bone-based image guided radiotherapy in prostate cancer patients
por: Napieralska, Aleksandra, et al.
Publicado: (2018)

Stereotactic Body Radiotherapy (SBRT) Reirradiation for Recurrent Pancreas Cancer
por: Dagoglu, Nergiz, et al.
Publicado: (2016)

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview
por: Zeng, Kang Liang, et al.
Publicado: (2019)

Stereotactic Body Radiotherapy (SBRT) for an Extracranial Arteriovenous Malformation of the Pelvis
por: Jooya, Alborz, et al.
Publicado: (2021)

Clinical Evidence behind Stereotactic Radiotherapy for the Treatment of Ventricular Tachycardia (STAR)—A Comprehensive Review
por: Miszczyk, Marcin, et al.
Publicado: (2021)

Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
por: Lischalk, Jonathan W., et al.
Publicado: (2016)

Editorial: Clinical Application of Stereotactic Body Radiotherapy (SBRT): Cranium to Prostate
por: Vargo, John A., et al.
Publicado: (2015)

Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma
por: Gkika, Eleni, et al.
Publicado: (2017)

Stereotactic body radiotherapy (SBRT) for locally advanced extrahepatic and intrahepatic cholangiocarcinoma
por: Sandler, Kiri A., et al.
Publicado: (2016)

Identifying predictors of on-table adaptation for pancreas stereotactic body radiotherapy (SBRT)
por: Wu, Trudy C., et al.
Publicado: (2023)

Investigation of DNA Damage and Cell-Cycle Distribution in Human Peripheral Blood Lymphocytes under Exposure to High Doses of Proton Radiotherapy
por: Miszczyk, Justyna
Publicado: (2021)

Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma
por: Barney, Brandon M, et al.
Publicado: (2012)

Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments
por: Navarria, Pierina, et al.
Publicado: (2014)

Feasibility of Adaptive MR-guided Stereotactic Body Radiotherapy (SBRT) of Lung Tumors
por: Padgett, Kyle R, et al.
Publicado: (2018)

Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases
por: Yeung, Rosanna, et al.
Publicado: (2017)

Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)
por: Habl, Gregor, et al.
Publicado: (2017)

Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients
por: König, Laila, et al.
Publicado: (2020)

Stereotactic body radiotherapy (SBRT) for central and ultracentral node-negative lung tumors
por: Owen, Dawn, et al.
Publicado: (2020)

The effectiveness and side effects of conformal external beam radiotherapy combined with high-dose-rate brachytherapy boost compared to conformal external beam radiotherapy alone in patients with prostate cancer
por: Smolska-Ciszewska, Beata, et al.
Publicado: (2015)

Simultaneous integrated boost with stereotactic radiotherapy for dominant intraprostatic lesion of localized prostate cancer: a dosimetric planning study
por: Kim, Yeon Joo, et al.
Publicado: (2020)

Outcomes of Stereotactic Body Radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodules
por: Owen, Dawn, et al.
Publicado: (2015)

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Lung Nodules: A Single Institution Series
por: Wegner, Rodney E., et al.
Publicado: (2019)

Stereotactic Body Radiotherapy (SBRT) of Pancreatic Cancer—A Critical Review and Practical Consideration
por: Burkoň, Petr, et al.
Publicado: (2022)

Multiple Primary Lung Cancers: Treatment Outcomes After Stereotactic Body Radiotherapy (SBRT)
por: Choi, Gyujae, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tgvuq3a62iq137u405rtq199hi